Boston Scientific (BSX) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.66% |
| Dec 31, 2025 | 0.09% |
| Sep 30, 2025 | 13.68% |
| Jun 30, 2025 | 30.81% |
| Mar 31, 2025 | 5.76% |
| Dec 31, 2024 | 2.94% |
| Sep 30, 2024 | -44.56% |
| Jun 30, 2024 | -85.13% |
| Mar 31, 2024 | 5.19% |
| Dec 31, 2023 | -33.41% |
| Sep 30, 2023 | 1.92% |
| Jun 30, 2023 | 4.30% |
| Mar 31, 2023 | -1.62% |
| Dec 31, 2022 | -37.62% |
| Sep 30, 2022 | -9.99% |
| Jun 30, 2022 | 10.33% |
| Mar 31, 2022 | 0.12% |
| Dec 31, 2021 | -57.92% |
| Sep 30, 2021 | -52.38% |
| Jun 30, 2021 | -43.61% |
| Mar 31, 2021 | -42.93% |
| Dec 31, 2020 | -40.30% |
| Sep 30, 2020 | -44.01% |
| Jun 30, 2020 | -15.86% |
| Mar 31, 2020 | -22.29% |
| Dec 31, 2019 | 5.90% |
| Sep 30, 2019 | -7.73% |
| Jun 30, 2019 | 19.19% |
| Mar 31, 2019 | -70.15% |
| Dec 31, 2018 | 7.62% |
| Sep 30, 2018 | -6.46% |
| Jun 30, 2018 | 17.06% |
| Mar 31, 2018 | -1.38% |
| Dec 31, 2017 | 1.91% |
| Sep 30, 2017 | 9.81% |
| Jun 30, 2017 | -5.11% |
| Mar 31, 2017 | -2.86% |
| Dec 31, 2016 | 6.00% |
| Sep 30, 2016 | 3.00% |
| Jun 30, 2016 | -23.25% |
| Mar 31, 2016 | 10.69% |
| Dec 31, 2015 | -8.41% |
| Sep 30, 2015 | 10.92% |
| Jun 30, 2015 | -2.17% |
| Mar 31, 2015 | 14.15% |
| Dec 31, 2014 | 7.44% |
| Sep 30, 2014 | 29.18% |
| Jun 30, 2014 | 21.45% |
| Mar 31, 2014 | 26.61% |